Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | prolyl endopeptidase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | oligopeptidase b | prolyl endopeptidase | 710 aa | 630 aa | 27.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.026 | 0.2148 | 0.1237 |
Loa Loa (eye worm) | hypothetical protein | 0.0385 | 0.3517 | 0.2764 |
Trypanosoma brucei | prolyl endopeptidase | 0.0158 | 0.104 | 0.2957 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.026 | 0.2148 | 0.1237 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0385 | 0.3517 | 0.2764 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0385 | 0.3517 | 0.2764 |
Brugia malayi | leucyl aminopeptidase | 0.0385 | 0.3517 | 0.2764 |
Toxoplasma gondii | hypothetical protein | 0.0385 | 0.3517 | 1 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0385 | 0.3517 | 0.2764 |
Loa Loa (eye worm) | hypothetical protein | 0.0979 | 1 | 1 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0385 | 0.3517 | 0.2764 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0385 | 0.3517 | 0.2764 |
Schistosoma mansoni | nicalin (M28 family) | 0.0385 | 0.3517 | 0.2764 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0385 | 0.3517 | 1 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0158 | 0.104 | 0.2957 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.0142 | 0.0859 | 0.2442 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0385 | 0.3517 | 0.5 |
Leishmania major | glutaminyl cyclase, putative | 0.0385 | 0.3517 | 1 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0385 | 0.3517 | 1 |
Brugia malayi | FXNA | 0.0385 | 0.3517 | 0.2764 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0385 | 0.3517 | 0.2764 |
Mycobacterium ulcerans | hypothetical protein | 0.0385 | 0.3517 | 1 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0385 | 0.3517 | 1 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0385 | 0.3517 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0385 | 0.3517 | 0.2764 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0158 | 0.104 | 0.2957 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0979 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0385 | 0.3517 | 0.2764 |
Mycobacterium tuberculosis | Conserved protein | 0.0385 | 0.3517 | 1 |
Onchocerca volvulus | 0.0385 | 0.3517 | 0.2764 | |
Leishmania major | hypothetical protein, conserved | 0.0385 | 0.3517 | 1 |
Toxoplasma gondii | peptidase, M28 family protein | 0.0385 | 0.3517 | 1 |
Schistosoma mansoni | glutaminyl-peptide cyclotransferase-related | 0.0385 | 0.3517 | 0.2764 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0385 | 0.3517 | 0.2764 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0979 | 1 | 1 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0385 | 0.3517 | 0.2764 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0385 | 0.3517 | 0.5 |
Schistosoma mansoni | Fxna peptidase (M28 family) | 0.0385 | 0.3517 | 0.2764 |
Brugia malayi | hypothetical protein | 0.026 | 0.2148 | 0.1237 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0385 | 0.3517 | 0.2764 |
Brugia malayi | nicalin | 0.0385 | 0.3517 | 0.2764 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0385 | 0.3517 | 0.5 |
Schistosoma mansoni | glutaminyl cyclase (M28 family) | 0.0979 | 1 | 1 |
Loa Loa (eye worm) | leucyl aminopeptidase | 0.0385 | 0.3517 | 0.2764 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0979 | 1 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.026 | 0.2148 | 0.1237 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0385 | 0.3517 | 0.5 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0385 | 0.3517 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0385 | 0.3517 | 0.2764 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0063 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3 nM | Inhibition of prolyl oligopeptidase in human LN229 cell extracts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis by fluorimetric assay | ChEMBL. | 19888757 |
IC50 (binding) | = 5 nM | Inhibition of prolyl oligopeptidase in human LNZ308 cell extracts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis by fluorimetric assay | ChEMBL. | 19888757 |
IC50 (binding) | = 7 nM | Inhibition of prolyl oligopeptidase in human HCEC cell extracts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis by fluorimetric assay | ChEMBL. | 19888757 |
IC50 (binding) | = 20 nM | Inhibition of prolyl oligopeptidase in intact human HCEC cells assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis by fluorimetric assay | ChEMBL. | 19888757 |
IC50 (binding) | = 28 nM | Inhibition of prolyl oligopeptidase in intact human LN229 cells assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis by fluorimetric assay | ChEMBL. | 19888757 |
IC50 (binding) | = 29 nM | Inhibition of prolyl oligopeptidase in intact human LNZ308 cells assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis by fluorimetric assay | ChEMBL. | 19888757 |
Inhibition (binding) | Inhibition of DPP4 in human fibroblast extracts assessed as blockade of Gly-Pro-AMC substrate hydrolysis at 100 uM by fluorimetric assay | ChEMBL. | 19888757 | |
Inhibition (binding) | Inhibition of DPP4 in intact human fibroblasts assessed as blockade of Gly-Pro-AMC substrate hydrolysis at 100 uM by fluorimetric assay | ChEMBL. | 19888757 | |
Inhibition (binding) | Inhibition of DPP4 in human astrocyte derived cell extracts assessed as blockade of Gly-Pro-AMC substrate hydrolysis at 100 uM by fluorimetric assay | ChEMBL. | 19888757 | |
Inhibition (binding) | Inhibition of DPP4 in intact human brain derived endothelial cells assessed as blockade of Gly-Pro-AMC substrate hydrolysis at 100 uM by fluorimetric assay | ChEMBL. | 19888757 | |
Inhibition (binding) | Inhibition of DPP4 in intact human astrocyte derived cells assessed as blockade of Gly-Pro-AMC substrate hydrolysis at 100 uM by fluorimetric assay | ChEMBL. | 19888757 | |
Inhibition (binding) | Inhibition of DPP4 in human brain derived endothelial cell extracts assessed as blockade of Gly-Pro-AMC substrate hydrolysis at 100 uM by fluorimetric assay | ChEMBL. | 19888757 | |
Inhibition (binding) | > 90 % | Inhibition of prolyl oligopeptidase in human astrocyte derived cell extracts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis at 20 uM by fluorimetric assay | ChEMBL. | 19888757 |
Inhibition (binding) | > 90 % | Inhibition of prolyl oligopeptidase in human brain derived endothelial cell extracts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis at 20 uM by fluorimetric assay | ChEMBL. | 19888757 |
Inhibition (binding) | > 90 % | Inhibition of prolyl oligopeptidase in human fibroblast extracts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis at 20 uM by fluorimetric assay | ChEMBL. | 19888757 |
Inhibition (binding) | > 90 % | Inhibition of prolyl oligopeptidase in intact human astrocyte derived cells assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis at 20 uM by fluorimetric assay | ChEMBL. | 19888757 |
Inhibition (binding) | > 90 % | Inhibition of prolyl oligopeptidase in intact human brain derived endothelial cells assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis at 20 uM by fluorimetric assay | ChEMBL. | 19888757 |
Inhibition (binding) | > 90 % | Inhibition of prolyl oligopeptidase in intact human fibroblasts assessed as blockade of Z-Gly-Pro-AMC substrate hydrolysis at 20 uM by fluorimetric assay | ChEMBL. | 19888757 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.